Apixaban in Subjects With Peritoneal Dialysis
NCT04006093
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Chronic Renal Insufficiency
Peritoneal Dialysis
Interventions
DRUG:
Apixaban single dose 5mg
Sponsor
University Hospital, Caen
Collaborators
[object Object]